Summary of BIORESTORATIVE THERAPIES, INC.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On February 10, 2012, BioRestorative Therapies, Inc. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting"). The following is a listing of the votes cast for or withheld, and the number of broker non-votes, with respect to each nominee for director and a listing of the votes cast for and against, as well as abstentions and broker-non votes, with respect to each other matter voted upon at the Annual Meeting. Each of the nominees was elected as a director and each of the other matters was approved.

1. Election of Board of Directors:

                                              Number of Shares
                                  For          Withheld       Broker Non-Votes
          Mark Weinreb         321,129,947       537,305             62,689,403
          A. Jeffrey Radov     321,129,947       537,305             62,689,403
          Joel San Antonio     321,129,947       537,305             62,689,403

2. Approval of an amendment to the Company's Articles of Incorporation to increase the number of shares of common stock authorized to be issued by the Company from 800,000,000 to 1,500,000,000:

                         For                  355,101,393
                         Against               29,255,262
                         Abstentions                    -
                         Broker Non-Votes               -

3. Authorization of the Board of Directors to effect a reverse stock split of the Company's common stock by a ratio or not less than 1-for-10 and not more than 1-for-50, with the Board of Directors of the Company having discretion as to whether or not the reverse split is to be effected, and with the exact ratio of any reverse split to be set at a whole number within the above range as determined by the Company's Board of Directors in its discretion:

                         For                  353,629,250
                         Against               30,727,405
                         Abstentions                    -
                         Broker Non-Votes               -

Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On February 10, 2012, the Company and Mark Weinreb, its Chief Executive Officer, agreed to extend the term of Mr. Weinreb's employment agreement with the Company for a period of two years to October 4, 2015. During the two year extension period, the annual compensation payable to Mr. Weinreb shall remain at the level payable to him for the twelve month period ended October 4, 2013.